The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107625977 10762597 7 F 2012 20160912 20150204 20160922 PER US-PFIZER INC-2015041425 PFIZER 74.00 YR M Y 105.00000 KG 20160922 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107625977 10762597 1 PS SUTENT SUNITINIB MALATE 1 50 MG, UNK Y 21938 50 MG CAPSULE, HARD
107625977 10762597 2 SS SUTENT SUNITINIB MALATE 1 37.5 MG, UNK Y 21938 37.5 MG CAPSULE, HARD
107625977 10762597 3 SS SUTENT SUNITINIB MALATE 1 Oral 25 MG, CYCLIC (ONCE A DAY 28 ON AND 14 OFF/ 1 P.O. Q DAY 4 WEEKS ON, 2 WEEKS OFF) Y Z168A 21938 25 MG CAPSULE, HARD
107625977 10762597 4 SS SUTENT SUNITINIB MALATE 1 UNK Y 4708A 21938 CAPSULE, HARD
107625977 10762597 5 SS SUTENT SUNITINIB MALATE 1 35 UNK, UNK Y 21938 35 MG CAPSULE, HARD
107625977 10762597 6 C TERAZOSIN TERAZOSINTERAZOSIN HYDROCHLORIDE 1 10 MG, DAILY 0 10 MG
107625977 10762597 7 C PROPAFENONE. PROPAFENONE 1 150 MG, 3X/DAY 0 150 MG TID
107625977 10762597 8 C LISINOPRIL. LISINOPRIL 1 40 MG, DAILY 0 40 MG
107625977 10762597 9 C SODIUM POLYSTYRENE SULFONATE. SODIUM POLYSTYRENE SULFONATE 1 50 MG, 2X/WEEK 0 50 MG BIW
107625977 10762597 10 C SODIUM POLYSTYRENE SULFONATE. SODIUM POLYSTYRENE SULFONATE 1 15 G, 2X/WEEK 0 15 G BIW
107625977 10762597 11 C CHLORTHALIDONE. CHLORTHALIDONE 1 25 MG, AS NEEDED 0 25 MG
107625977 10762597 12 C FLOMAX TAMSULOSIN HYDROCHLORIDE 1 0.4 MG, 1X/DAY 0 .4 MG QD
107625977 10762597 13 C FLOMAX TAMSULOSIN HYDROCHLORIDE 1 0.04 MG, 1X/DAY 0 .04 MG QD
107625977 10762597 14 C VITAMIN D CHOLECALCIFEROL 1 2000 IU, 1X/DAY 0 2000 IU QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107625977 10762597 1 Metastatic renal cell carcinoma
107625977 10762597 6 Hypertension
107625977 10762597 7 Arrhythmia
107625977 10762597 8 Hypertension
107625977 10762597 12 Prostatic disorder

Outcome of event

Event ID CASEID OUTC COD
107625977 10762597 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
107625977 10762597 Abdominal discomfort
107625977 10762597 Blister
107625977 10762597 Diarrhoea
107625977 10762597 Epistaxis
107625977 10762597 Hyperhidrosis
107625977 10762597 Hyperkeratosis
107625977 10762597 Nasal discomfort
107625977 10762597 Nasal dryness
107625977 10762597 Nausea
107625977 10762597 Pain in extremity
107625977 10762597 Paraesthesia
107625977 10762597 Pigmentation disorder
107625977 10762597 Skin exfoliation
107625977 10762597 Skin fissures
107625977 10762597 Skin irritation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
107625977 10762597 1 2012 0
107625977 10762597 3 2012 0
107625977 10762597 4 2012 0
107625977 10762597 6 1995 0
107625977 10762597 7 2007 0
107625977 10762597 8 1995 0
107625977 10762597 10 2014 0
107625977 10762597 11 2014 0
107625977 10762597 12 2015 0
107625977 10762597 13 2015 0